Related Experiment Videos

[Immunotherapy of colorectal cancers]

Y Bécouarn¹, J F Seitz, H Perrier

¹Service d'Oncologie Digestive et de Gastroentérologie, Institut Bergonié, Bordeaux.

Gastroenterologie Clinique Et Biologique

|February 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023

Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens.

ESMO open·2023

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.

British journal of cancer·2014

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2011

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

British journal of cancer·2008

See all related articles